Endothelial dysfunction markers as a therapeutic target for Sildenafil treatment and effects on metabolic control in type 2 diabetes

Is chronic inhibition of phosphodiesterase type 5 cardioprotective and safe? A meta-analysis of randomized controlled trials

(2014) Elisa Giannetta et al.   BMC Medicine

Chronic Inhibition of cGMP Phosphodiesterase 5A Improves Diabetic Cardiomyopathy

(2012) Elisa Giannetta et al.   CIRCULATION

Erectile dysfunction and diabetes: A review of the current evidence-based medicine and a synthesis of the main available therapies

(2011) V. Phé et al.   DIABETES & METABOLISM

Endothelial Dysfunction in the Apolipoprotein E-deficient Mouse: insights into the influence of diet, gender and aging

(2011) Silvana S Meyrelles et al.   Lipids in Health and Disease

Endothelial Dysfunction as a Target for Prevention of Cardiovascular Disease

(2009) D. Versari et al.   DIABETES CARE

Serum Biomarker Measurements of Endothelial Function and Oxidative Stress After Daily Dosing of Sildenafil in Type 2 Diabetic Men With Erectile Dysfunction

(2008) Arthur L. Burnett et al.   JOURNAL OF UROLOGY